MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib

Agreement On Tasigna Generics Represents First Such Deal For A Cancer Medicine

 
• By David Wallace
  
Novartis logo building
Novartis has signed a voluntary licensing deal with the MPP for nilotinib • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business